GC
PBYI icon

Globeflex Capital’s Puma Biotechnology PBYI Stock Holding History

Globeflex Capital’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
382,807
+33,156
+9% +$243K 0.4% 80
2026
Q1 		$2.23M Sell
349,651
-102,955
-23% -$664K 0.34% 87
2025
Q4 		$2.69M Hold
452,606
– – 0.41% 76
2025
Q3 		$2.4M Hold
452,606
– – 0.37% 79
2025
Q2 		$1.55M Hold
452,606
– – 0.13% 142
2025
Q1 		$1.34M Hold
452,606
– – 0.12% 141
2024
Q4 		$1.38M Hold
452,606
– – 0.12% 152
2024
Q3 		$1.15M Hold
452,606
– – 0.11% 165
2024
Q2 		$1.48M Sell
452,606
-39,145
-8% -$172K 0.15% 140
2024
Q1 		$2.61M Sell
491,751
-46,808
-9% -$252K 0.25% 97
2023
Q4 		$2.33M Hold
538,559
– – 0.24% 106
2023
Q3 		$1.42M Sell
538,559
-22,971
-4% -$78.2K 0.17% 140
2023
Q2 		$1.98M Hold
561,530
– – 0.22% 118
2023
Q1 		$1.74M Hold
561,530
– – 0.21% 120
2022
Q4 		$2.38M Sell
561,530
-9,310
-2% -$32.1K 0.3% 86
2022
Q3 		$1.35M Buy
570,840
+151,518
+36% +$442K 0.23% 132
2022
Q2 		$1.2M Buy
419,322
+69,098
+20% +$172K 0.29% 98
2022
Q1 		$1.01M Sell
350,224
-63,157
-15% -$163K 0.2% 138
2021
Q4 		$1.26M Sell
413,381
-311
-0.1% -$1.35K 0.26% 119
2021
Q3 		$2.9M Sell
413,692
-34,009
-8% -$255K 0.63% 26
2021
Q2 		$4.11M Buy
447,701
+19,021
+4% +$193K 0.74% 15
2021
Q1 		$4.17M Buy
428,680
+373,653
+679% +$4.17M 0.76% 15
2020
Q4 		$565K Hold
55,027
– – 0.12% 269
2020
Q3 		$555K Sell
55,027
-8,199
-13% -$83.5K 0.15% 228
2020
Q2 		$659K Buy
+63,226
New +$654K 0.17% 219

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Globeflex Capital's PBYI Position: Q2 2026 in Review

Globeflex Capital increased its Puma Biotechnology (PBYI) stake by 9.5% in Q2 2026, buying an estimated $243K and bringing the position to 382,807 shares worth $3.1M. The position accounts for 0.4% of the portfolio, ranked #80.

Globeflex Capital first reported a position in PBYI in Q2 2020 and has held it in 25 quarters since. The position peaked at $4.17M in Q1 2021. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

  • Globeflex Capital held 382,807 shares of Puma Biotechnology worth $3.1M as of Q2 2026.
  • Globeflex Capital bought 33,156 Puma Biotechnology shares in Q2 2026, an estimated $243K.
  • Puma Biotechnology made up 0.4% of Globeflex Capital's portfolio in Q2 2026, its #80 holding.
  • Globeflex Capital first reported a position in Puma Biotechnology in Q2 2020 and has held it in 25 quarters since.
  • Globeflex Capital's Puma Biotechnology position peaked at $4.17M in Q1 2021.
  • 160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.